A study testing whether tradipitant from Vanda Pharmaceuticals, an investigational anti-nausea medicine, can reduce nausea and vomiting.
- Who can join
- Adults 18 to 65, have nausea and vomiting, BMI 25+.
- What you take
- Tradipitant, given as part of the study at no cost to you. Some participants may receive a placebo (an inactive version) instead, decided at random.
- How long it lasts
- The study runs about 9 months.
- What you get
- The study medication and study-related care at no cost. Compensation varies by study site; many cover travel and provide the study medication at no cost. The trial coordinator will explain what that site offers before you join.
What this study is for
Full study title: A Study to Evaluate Tradipitant on Treating Nausea and Vomiting Induced by GLP-1R Agonist Use.
Primary condition: Nausea and Vomiting. Also studied in: Obesity.
Who can join, in detail
Key inclusion criteria
- Body Mass Index >= 25 and < 40 kg/m^2
- No serious medical problems or chronic diseases, specifically no type I or type II diabetes
Key exclusion criteria
- Another disorder that contributes to gastrointestinal symptoms
- History of intolerance and/or hypersensitivity to NK-1 receptor antagonists
- History of intolerance and/or hypersensitivity to GLP-1 receptor agonists
- Exposure to any investigational medication within the past 60 days
Where this study is enrolling
This trial has 10 US sites across 6 states. Contact the site coordinator directly to start the screening process.
California
- Vanda Investigational SiteLos Angeles, CaliforniaVanda Pharmaceuticals202-734-3400
- Vanda Investigational SiteSan Diego, CaliforniaVanda Pharmaceuticals202-734-3400
- Vanda Investigational SiteSan Jose, CaliforniaVanda Pharmaceuticals(202) 734-3400
Florida
- Vanda Investigational SiteTampa, FloridaVanda Pharmaceuticals(202) 734-3400
New Jersey
- Vanda Investigational SiteHamilton, New JerseyVanda Pharmaceuticals(202) 734-3400
New York
- Vanda Investigational SiteNew York, New YorkVanda Pharmaceuticals202-734-3400
- Vanda Investigational SiteSyosset, New YorkVanda Pharmaceuticals(202) 734-3400
Texas
- Vanda Investigational SitePlano, TexasVanda Pharmaceuticals(202) 734-3400
- Vanda Investigational SiteSan Antonio, TexasVanda Pharmaceuticals(202) 734-3400
Virginia
- Vanda Investigational SiteBurke, VirginiaVanda Pharmaceuticals(202) 734-3400
Timeline
Started enrolling: 2026-03-27. Expected completion: 2026-12-01. Last updated on ClinicalTrials.gov: 2026-04-20.
Official source
We sync this data quarterly from ClinicalTrials.gov, the federal registry for clinical research. Before contacting a site, verify the trial is still recruiting on the official page:
Other GLP-1 clinical trials
Back to the full directory → or take the matching quiz if you want clinical trials filtered to your conditions and location.